Cargando…

Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis

Introduction: The prevention of schizophrenia and other psychotic disorders has led researchers to focus on early identification of individuals at clinical high risk (CHR) for psychosis and to treat the at-risk symptoms in the pre-psychotic period. Although at-risk symptoms such as attenuated halluc...

Descripción completa

Detalles Bibliográficos
Autores principales: Traber-Walker, Nina, Gerstenberg, Miriam, Metzler, Sibylle, Joris, Maria Raquel, Karr, Markus, Studer, Nadja, Zulauf Logoz, Marina, Roth, Alexander, Rössler, Wulf, Walitza, Susanne, Franscini, Maurizia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562244/
https://www.ncbi.nlm.nih.gov/pubmed/31244692
http://dx.doi.org/10.3389/fpsyt.2019.00384
_version_ 1783426258251546624
author Traber-Walker, Nina
Gerstenberg, Miriam
Metzler, Sibylle
Joris, Maria Raquel
Karr, Markus
Studer, Nadja
Zulauf Logoz, Marina
Roth, Alexander
Rössler, Wulf
Walitza, Susanne
Franscini, Maurizia
author_facet Traber-Walker, Nina
Gerstenberg, Miriam
Metzler, Sibylle
Joris, Maria Raquel
Karr, Markus
Studer, Nadja
Zulauf Logoz, Marina
Roth, Alexander
Rössler, Wulf
Walitza, Susanne
Franscini, Maurizia
author_sort Traber-Walker, Nina
collection PubMed
description Introduction: The prevention of schizophrenia and other psychotic disorders has led researchers to focus on early identification of individuals at clinical high risk (CHR) for psychosis and to treat the at-risk symptoms in the pre-psychotic period. Although at-risk symptoms such as attenuated hallucinations or delusions are common in adolescents and associated with a marked reduction in global functioning, the evidence base of effective interventions for adolescents at CHR state and even first-episode psychosis is limited. Thus, the present protocol describes a study design that combines therapy modules for CHR adolescents with a smartphone application supporting the young individuals between the therapy sessions. The treatment approach “Robin” is based on existing therapy strategies for adolescents with first episode of psychosis and the available recommendations for adults with at-risk symptoms. Methods: The evaluation aims firstly to compare the efficacy of Robin in 30 CHR adolescents aged 14–18 to an active control group (treatment as usual) from a previous study. Primary outcome measures will be at-risk symptomatology, comorbid diagnosis, functioning, self-efficacy, and quality of life. For the prospective intervention condition (16 weekly individual sessions + a minimum 4 family sessions), help-seeking adolescents with CHR for psychosis, aged 14–18, will be recruited over 3 years. At-risk and comorbid symptoms, functioning, self-efficacy, and quality of life are monitored at six time points (baseline, during the treatment period; immediately after intervention; and 6, 12, and 24 months later) and compared with the respective measures of the active control group. Discussion: To the best of our knowledge, this is the first controlled trial to test the efficacy of a specific early psychosis treatment in combination with a smartphone application for adolescents at CHR for developing psychosis. The results of the study are expected to add information that may substantially decrease the burden of CHR adolescents and increase their resilience. It may offer age-adapted and targeted strategies to guide clinicians in the treatment of these vulnerable individuals. Furthermore, research in the field of early intervention will be enriched by our findings. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03829527.
format Online
Article
Text
id pubmed-6562244
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-65622442019-06-26 Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis Traber-Walker, Nina Gerstenberg, Miriam Metzler, Sibylle Joris, Maria Raquel Karr, Markus Studer, Nadja Zulauf Logoz, Marina Roth, Alexander Rössler, Wulf Walitza, Susanne Franscini, Maurizia Front Psychiatry Psychiatry Introduction: The prevention of schizophrenia and other psychotic disorders has led researchers to focus on early identification of individuals at clinical high risk (CHR) for psychosis and to treat the at-risk symptoms in the pre-psychotic period. Although at-risk symptoms such as attenuated hallucinations or delusions are common in adolescents and associated with a marked reduction in global functioning, the evidence base of effective interventions for adolescents at CHR state and even first-episode psychosis is limited. Thus, the present protocol describes a study design that combines therapy modules for CHR adolescents with a smartphone application supporting the young individuals between the therapy sessions. The treatment approach “Robin” is based on existing therapy strategies for adolescents with first episode of psychosis and the available recommendations for adults with at-risk symptoms. Methods: The evaluation aims firstly to compare the efficacy of Robin in 30 CHR adolescents aged 14–18 to an active control group (treatment as usual) from a previous study. Primary outcome measures will be at-risk symptomatology, comorbid diagnosis, functioning, self-efficacy, and quality of life. For the prospective intervention condition (16 weekly individual sessions + a minimum 4 family sessions), help-seeking adolescents with CHR for psychosis, aged 14–18, will be recruited over 3 years. At-risk and comorbid symptoms, functioning, self-efficacy, and quality of life are monitored at six time points (baseline, during the treatment period; immediately after intervention; and 6, 12, and 24 months later) and compared with the respective measures of the active control group. Discussion: To the best of our knowledge, this is the first controlled trial to test the efficacy of a specific early psychosis treatment in combination with a smartphone application for adolescents at CHR for developing psychosis. The results of the study are expected to add information that may substantially decrease the burden of CHR adolescents and increase their resilience. It may offer age-adapted and targeted strategies to guide clinicians in the treatment of these vulnerable individuals. Furthermore, research in the field of early intervention will be enriched by our findings. Clinical Trial Registration: www.ClinicalTrials.gov, identifier NCT03829527. Frontiers Media S.A. 2019-06-06 /pmc/articles/PMC6562244/ /pubmed/31244692 http://dx.doi.org/10.3389/fpsyt.2019.00384 Text en Copyright © 2019 Traber-Walker, Gerstenberg, Metzler, Joris, Karr, Studer, Zulauf Logoz, Roth, Rössler, Walitza and Franscini http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Traber-Walker, Nina
Gerstenberg, Miriam
Metzler, Sibylle
Joris, Maria Raquel
Karr, Markus
Studer, Nadja
Zulauf Logoz, Marina
Roth, Alexander
Rössler, Wulf
Walitza, Susanne
Franscini, Maurizia
Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title_full Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title_fullStr Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title_full_unstemmed Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title_short Evaluation of the Combined Treatment Approach “Robin” (Standardized Manual and Smartphone App) for Adolescents at Clinical High Risk for Psychosis
title_sort evaluation of the combined treatment approach “robin” (standardized manual and smartphone app) for adolescents at clinical high risk for psychosis
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6562244/
https://www.ncbi.nlm.nih.gov/pubmed/31244692
http://dx.doi.org/10.3389/fpsyt.2019.00384
work_keys_str_mv AT traberwalkernina evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT gerstenbergmiriam evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT metzlersibylle evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT jorismariaraquel evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT karrmarkus evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT studernadja evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT zulauflogozmarina evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT rothalexander evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT rosslerwulf evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT walitzasusanne evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis
AT franscinimaurizia evaluationofthecombinedtreatmentapproachrobinstandardizedmanualandsmartphoneappforadolescentsatclinicalhighriskforpsychosis